Get started
Author

Li‐An K. Brown

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
2017 · Guy E Thwaites, Matthew Scarborough, et al. · The Lancet · 199
PDF
Treatment of chronic or relapsing COVID-19 in immunodeficiency
2021 · Li-An K. Brown, Ed Moran, et al. · Journal of Allergy and Clinical Immunology · 89
PDF
Norovirus infection in primary immune deficiency
2017 · Li‐An K. Brown, Ian Clark, et al. · Reviews in Medical Virology · 51
PDF
Mutagenesis in Norovirus in Response to Favipiravir Treatment
2018 · Christopher Ruis, Li-An K. Brown, et al. · New England Journal of Medicine · 47
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19
2022 · David M. Lowe, Li-An K. Brown, et al. · PLoS Medicine · 32
A comprehensive characterization of chronic norovirus infection in immunodeficient hosts
2019 · Li-An K. Brown, Christopher Ruis, et al. · Journal of Allergy and Clinical Immunology · 31
PDF
Surveillance for COVID-19-associated pulmonary aspergillosis
2020 · Li-An K Brown, Jayne Ellis, et al. · The Lancet Microbe · 23
PDF
Clinical Features, Immunological Characteristics, and Treatment Outcomes of Campylobacter spp. Infections in Patients With Common Variable Immunodeficiency
2023 · Adriel Roa-Bautista, Li-An K. Brown, et al. · The Journal of Allergy and Clinical Immunology In Practice · 20
PDF
Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy
2026 · Sarah Buddle, Li-An K. Brown, et al. · Nature Medicine · 17
PDF
Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial
2021 · Li-An K. Brown, Nick Freemantle, et al. · Trials · 16
PDF
Use of Cefiderocol in the Management of Children With Infection or Colonization With Multi-drug Resistant Gram-negative Bacteria: A Retrospective, Single-center Case Series
2024 · Hanna Schmid, Li-An K. Brown, et al. · The Pediatric Infectious Disease Journal · 13
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Comparison of endoscopic sinus sampling versus intracranial sampling for microbiological diagnosis of intracranial infection in children: a case series and literature review
2023 · Michelle Masayo Kameda-Smith, Maya Mendoza, et al. · Child s Nervous System · 12
PDF
Favipiravir, lopinavir-ritonavir or combination therapy (FLARE): a randomised, double blind, 2x2 factorial placebo-controlled trial of early antiviral therapy in COVID-19
2022 · David M Lowe, Li-An K Brown, et al. · medRxiv · 10
PDF
Safety of in vivo gene therapy in children: mechanisms and management of liver injury
2026 · Rebecca Jeyaraj, Li-An K Brown, et al. · The Lancet Child & Adolescent Health · 4
Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir–ritonavir in patients with COVID‐19
2026 · Akosua A. Agyeman, Laura Buggiotti, et al. · British Journal of Clinical Pharmacology · 1
P5 promoter-mediated incorporation explains REP/CAP manufacturing contaminants in patient liver after rAAV gene therapy
2026 · Mark A. Brimble, Shaoyuan Tan, et al. · medRxiv
PDF
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases
PDF
Contaminating manufacturing plasmids and disrupted vector genomes present in liver tissue following adeno-associated virus gene therapy
2025 · Sarah Buddle, Li-An K Brown, et al. · medRxiv
PDF
Triterpenoids
2021 · Li-An Brown, Neil Stone, et al. · Elsevier eBooks
Characterisation and Treatment of Chronic Norovirus Infection in Immunodeficient Hosts
2016 · Li-An Brown
Works count: 18
Citation count: 564
H-index: 12
I10-index: 13
Year
Topic
Type